Butterfly Network, Inc. (BFLY) · Oct 29, 2026 · Earnings
Beat — Revenue $32.6M vs ~$28.4M consensus; adjusted EBITDA -$1.2M vs -$6M to -$9M guide
Butterfly Network earnings beat Q3 revenue and adjusted EBITDA guidance, with Embedded licensing pushing gross margin to a record 73%.
Butterfly is transitioning from a hardware-led portable-ultrasound business toward a higher-margin platform built around Embedded licensing, cloud software, AI, and enterprise/government distribution. Its prior quarter already established the direction—Embedded partnerships were lifting revenue and margins, while management had guided Q3 revenue to $26M–$30M and adjusted EBITDA loss to $6M–$9M.
The quarter materially cleared the operating bar. Revenue reached $32.6M, above both the top of management’s $30M range and the roughly $28.4M published consensus; adjusted EBITDA loss was only $1.2M, far better than the $6M–$9M guided loss. The important change is not simply another revenue beat: the company is producing much more contribution from licensing and software, which carries higher margins than probe sales. 〔0〕
| Q3 2026 | Q3 2025 | Consensus / guide | |
|---|---|---|---|
| Revenue (Financial Statements) | $32.6M (+51.7%) | $21.5M | ~$28.4M consensus |
| Software and other services (Financial Statements) | $17.0M (+144.8%) | $6.9M | |
| Gross margin (Gross Margin) | 73.0% | (17.5%) | |
| Adjusted EBITDA (Adjusted EBITDA reconciliation) | $(1.2)M | $(8.1)M | $(6)M–$(9)M guide |
| Net loss (Income Statement) | $(12.8)M | $(34.0)M | |
| Cash and cash equivalents (Balance Sheet) | $122.3M | $150.5M at Dec. 31 |
The mix shift is doing the heavy lifting. Software and other services nearly 2.5x year over year, while product revenue rose only about 7%. Management attributes the margin expansion to higher-return Butterfly Embedded licensing revenue and increased probe volume; adjusted gross margin reached 73.0%, up from 63.9% a year ago. This is stronger evidence that Embedded is becoming an economic engine rather than remaining a pipeline story.
The business pipeline also moved closer to commercialization. Butterfly said enterprise deals are converting into signed contracts, FedRAMP authorization opens larger federal opportunities, and Mendaera became the first partner to launch a commercial product built on Butterfly technology on October 1. Home & Community Care is now expected to generate first revenue in November, while the company is preparing a next-generation P5.1-powered product for early 2027. 〔1〕
The beat does not remove the funding and execution burden. Butterfly still posted a $12.8M GAAP net loss, used $32.4M of operating cash in the first nine months, and ended September with $122.3M of cash—down from $150.5M at year-end. Operating expenses also rose 19% year over year as the company invests ahead of growth. The quarter improves the economics of the model, but sustained cash generation still depends on Embedded commercialization and the new enterprise, federal, and home-care programs scaling beyond initial launches.
Bottom line: This is a genuine beat with better-than-expected profitability, and the quality of the result improved because high-margin Embedded revenue—not just probe volume—drove the upside. The story has advanced from promising partnerships toward early commercialization, though cash burn and execution remain unresolved.
Home & Community Care revenue, November
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!